Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss

Rinri Therapeutics secures £1.4 million Read more

Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss2019-11-11T15:58:46+00:00
Go to Top